The value of adriamycin and of mid-cycle treatment in multidrug therapy of unfavorable histology non-Hodgkin's lymphoma

G. J. Johnson, W. G. Costello, M. M. Oken

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'The value of adriamycin and of mid-cycle treatment in multidrug therapy of unfavorable histology non-Hodgkin's lymphoma'. Together they form a unique fingerprint.